Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

SEVERO MARTÍNEZ PELÁEZ: (16-2-1925/14-1-1998) Y LAS TRADICIONES INTELECTUALES EN SU OBRA

No tien

Prevalencia de enfermedad renal crónica en pacientes con diabetes mellitus e hipertensión arterial en el Hospital Escandón

Durante el periodo comprendido entre el 1 de agosto de 2014 y el 31 de julio de 2015 se llevó a cabo, en las instalaciones del Hospital Escandón I.A.P una revisión metódica de pacientes para tratar de identificar la principal causa de enfermedad renal crónica en la población atendida en el nosocomio..

¿Por qué si el agua es transparente uno ve el mar azul? Lo que se preguntan los niños sobre ciencias contestado en breves relatos de expertos

Este libro, cuyo título es precisamente una de las preguntas de los niños, una de aquellas que quizás nos hicimos cuando teníamos esas edades, nos mostró lo cerca que está la ciencia de cada uno, todas las inquietudes que se tienen sobre la misma y la oportunidad que tenemos si enriquecemos la escuela con espacios que permitan aprovechar dichas preguntas para enseñarles a pensar a nuestros niños, a despertar su curiosidad y a seguir teniendo ideas maravillosas

Financiamiento de la educación superior en América Latina Funding higher education in Latin America

El trabajo parte de un panorama general de la situación de la educación superior en América Latina, tanto de su crecimiento cuantitativo como de las políticas públicas más relevantes. En la segunda parte es analizada una de esas políticas, la de financiamiento de las universidades públicas. Para ese trabajo fueran utilizados los datos basados en los estudios de lesalc/UNESCO. Por fin, el texto discute un plan de acción para el establecimiento de una agenda de financiamiento en la educación superior.<br>This work is based on an overview of the situation of higher education in Latin America, both of its quantitative growth and its more relevant public policies. The second part examines one of those policies: that of funding public universities. The work used data based on studies by IESALC/UNESCO. Finally, an action plan is discussed for the establishment of an agenda to fund higher education

Role of age and comorbidities in mortality of patients with infective endocarditis.

The aim of this study was to analyse the characteristics of patients with IE in three groups of age and to assess the ability of age and the Charlson Comorbidity Index (CCI) to predict mortality. Prospective cohort study of all patients with IE included in the GAMES Spanish database between 2008 and 2015.Patients were stratified into three age groups: A total of 3120 patients with IE (1327  There were no differences in the clinical presentation of IE between the groups. Age ≥ 80 years, high comorbidity (measured by CCI),and non-performance of surgery were independent predictors of mortality in patients with IE.CCI could help to identify those patients with IE and surgical indication who present a lower risk of in-hospital and 1-year mortality after surgery, especially in th